
SNWV Stock Forecast & Price Target
SNWV Analyst Ratings
Bulls say
SANUWAVE Health Inc. demonstrated substantial financial growth in 2024, with a remarkable 60% year-over-year increase in sales, reaching $32.6 million, primarily fueled by both system sales and consumables. The company's adjusted EBITDA also showed significant improvement, rising by 28 percentage points to 22%, indicating enhanced operational efficiency and profitability. While operating expenses increased slightly due to non-cash stock-based compensation, the overall strong sales growth and positive EBITDA trends contribute to a favorable outlook for SANUWAVE Health's stock.
Bears say
The financial outlook for SANUWAVE Health reflects several challenges that could negatively impact its stock performance. First, the company's applicator usage declined modestly in the first quarter, a typical seasonal trend influenced by patient behavior and insurance deductible resets, which may hinder revenue growth. Additionally, key concerns surrounding margin compression, competitive pressures, reduced sales representative productivity, and potential manufacturing setbacks raise significant doubts about the company's ability to achieve sustainable financial performance.
This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.
SNWV Analyst Forecast & Price Prediction
Start investing in SNWV
Order type
Buy in
Order amount
Est. shares
0 shares